eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | small cell carcinoma |
| Symptom | C0032227|pleural effusion |
| Sentences | 12 |
| PubMedID- 20207133 | A phase i clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions. |
| PubMedID- 21625182 | Predictive value of f-18 fdg pet/ct for malignant pleural effusion in non-small cell lung cancer patients. |
| PubMedID- 24758329 | Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer. |
| PubMedID- 26005243 | The patients studied here are enrolled in a phase i clinical trial of hpph-mediated pdt for the treatment of non-small cell lung cancer with pleural effusion. |
| PubMedID- 20819493 | Objective: to compare the therapeutic effects of pleural perfusion of ndp and cddp in non-small cell lung cancer (nsclc) patients with malignant pleural effusion, their quality of life and toxic side effects. |
| PubMedID- 23523589 | The diagnostic value of apolipoprotein e in malignant pleural effusion associated with non-small cell lung cancer. |
| PubMedID- 23898708 | However, this condition is sometimes discovered, with or without a small amount of pleural effusion, at thoracotomy in patients with resectable non-small cell lung cancer. |
| PubMedID- 25999646 | Patients in this study are enrolled in a phase i clinical trial of hpph-mediated pdt for the treatment of non-small cell lung cancer with pleural effusion. |
| PubMedID- 23925664 | Vascular endothelial growth factor (vegf) is involved in non-small cell lung cancer (nsclc) with malignant pleural effusion (mpe), but little is known regarding the efficacy of bevacizumab (bev) with carboplatin-paclitaxel (cp) for nsclc with mpe. |
| PubMedID- 25764010 | Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions. |
| PubMedID- 26323029 | Purpose to determine the frequency and investigate possible mechanisms and prognostic relevance of minimal (<10-mm thickness) pleural effusion in patients with small cell lung cancer (sclc). |
| PubMedID- 25883534 | About 900 mv specific proteins were identified from pleural effusion of nonsmall cell lung cancer patients. |
Page: 1